Morepen Labs Completes First Phase Capacity Expansion

Date: 07/09/2026

Operational Update

Morepen Laboratories Limited has successfully completed the first phase of its manufacturing capacity expansion program ahead of the previously indicated timeline. The expansion was completed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Capacity Enhancement Details

• Installed reactor capacity for API and CDMO manufacturing has increased from 535 KL to 614 KL
• This represents a capacity increase of 79 KL
• The expansion was completed ahead of the previously indicated timeline

Strategic Impact

The capacity enhancement strengthens the Company's manufacturing readiness for the ongoing scale-up of commercial CDMO supplies. It also supports the Company's existing API business and future customer programs. This expansion represents an important milestone in Morepen's strategy to build a larger, scalable and globally compliant manufacturing platform, focused on long-duration customer partnerships and sustained growth across its API and CDMO businesses.